PortfoliosLab logoPortfoliosLab logo
BACHY vs. CVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BACHY vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bank of China Ltd ADR (BACHY) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BACHY achieves a 16.57% return, which is significantly lower than CVS's 35.72% return. Over the past 10 years, BACHY has outperformed CVS with an annualized return of 12.70%, while CVS has yielded a comparatively lower 4.02% annualized return.


BACHY

1D
0.10%
1M
-5.61%
6M
16.41%
YTD
16.57%
1Y
14.66%
3Y*
30.14%
5Y*
21.60%
10Y*
12.70%

CVS

1D
1.68%
1M
3.86%
6M
34.03%
YTD
35.72%
1Y
69.46%
3Y*
18.57%
5Y*
8.68%
10Y*
4.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BACHY vs. CVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BACHY
Bank of China Ltd ADR
16.57%23.87%43.09%14.58%10.54%14.31%-14.46%4.65%-8.11%15.60%
CVS
CVS Health Corporation
35.72%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%

Correlation

The correlation between BACHY and CVS is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 24, 2009

0.21

The correlation between BACHY and CVS shifts across timeframes, from 0.07 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BACHY:

$202.49B

CVS:

$135.12B

EPS

BACHY:

CN¥19.10

CVS:

$2.30

PE Ratio

BACHY:

5.74

CVS:

46.05

PS Ratio

BACHY:

1.15

CVS:

0.33

PB Ratio

BACHY:

0.47

CVS:

1.75

Total Revenue (TTM)

BACHY:

CN¥1.22T

CVS:

$407.91B

Gross Profit (TTM)

BACHY:

CN¥635.71B

CVS:

$56.59B

EBITDA (TTM)

BACHY:

CN¥307.28B

CVS:

$9.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BACHY vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BACHY
BACHY Risk / Return Rank: 6767
Overall Rank
BACHY Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
BACHY Sortino Ratio Rank: 6565
Sortino Ratio Rank
BACHY Omega Ratio Rank: 6363
Omega Ratio Rank
BACHY Calmar Ratio Rank: 6868
Calmar Ratio Rank
BACHY Martin Ratio Rank: 7171
Martin Ratio Rank

CVS
CVS Risk / Return Rank: 9292
Overall Rank
CVS Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 8888
Sortino Ratio Rank
CVS Omega Ratio Rank: 9292
Omega Ratio Rank
CVS Calmar Ratio Rank: 9292
Calmar Ratio Rank
CVS Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BACHY vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Bank of China Ltd ADR (BACHY) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BACHYCVSDifference
Sharpe ratioReturn per unit of total volatility

-1.47

Sortino ratioReturn per unit of downside risk

-1.40

Omega ratioGain probability vs. loss probability

1.15

1.40

-0.25

Calmar ratioReturn relative to maximum drawdown

1.10

4.25

-3.15

Martin ratioReturn relative to average drawdown

2.92

12.19

-9.27

BACHY vs. CVS - Sharpe Ratio Comparison

The current BACHY Sharpe Ratio is 0.78, which is lower than the CVS Sharpe Ratio of 2.25. The chart below compares the historical Sharpe Ratios of BACHY and CVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BACHY vs. CVS - Drawdown Comparison

The maximum BACHY drawdown since its inception was -53.68%, smaller than the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for BACHY and CVS.


Loading charts...

Drawdown Indicators


BACHYCVSDifference

Max Drawdown

Largest peak-to-trough decline

-53.68%

-64.07%

+10.39%

Max Drawdown (1Y)

Largest decline over 1 year

-13.43%

-16.44%

+3.01%

Max Drawdown (3Y)

Largest decline over 3 years

-15.70%

-43.98%

+28.28%

Max Drawdown (5Y)

Largest decline over 5 years

-16.91%

-56.79%

+39.88%

Max Drawdown (10Y)

Largest decline over 10 years

-40.98%

-56.79%

+15.81%

Current Drawdown

Current decline from peak

-5.61%

0.00%

-5.61%

Average Drawdown

Average peak-to-trough decline

-19.79%

-19.51%

-0.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.03%

5.74%

-0.71%

Volatility

BACHY vs. CVS - Volatility Comparison

Bank of China Ltd ADR (BACHY) has a higher volatility of 10.00% compared to CVS Health Corporation (CVS) at 7.04%. This indicates that BACHY's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BACHYCVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.00%

7.04%

+2.96%

Volatility (6M)

Calculated over the trailing 6-month period

15.16%

26.30%

-11.14%

Volatility (1Y)

Calculated over the trailing 1-year period

18.82%

31.05%

-12.23%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.03%

30.07%

-10.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.70%

29.37%

-8.67%

Dividends

BACHY vs. CVS - Dividend Comparison

BACHY's dividend yield for the trailing twelve months is around 5.04%, more than CVS's 2.51% yield.


PositionTTM20252024202320222021202020192018201720162015
BACHY
Bank of China Ltd ADR
5.04%8.52%6.46%8.92%9.64%8.57%7.99%5.32%5.42%4.08%11.53%7.39%
CVS
CVS Health Corporation
2.51%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%

Financials

BACHY vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between Bank of China Ltd ADR and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00B150.00B200.00B250.00B300.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
311.94B
100.43B
(BACHY) Total Revenue
(CVS) Total Revenue
Please note, different currencies. BACHY values in CNY, CVS values in USD

BACHY vs. CVS - Profitability Comparison

The chart below illustrates the profitability comparison between Bank of China Ltd ADR and CVS Health Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
45.9%
15.6%
Portfolio components
BACHY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Bank of China Ltd ADR reported a gross profit of 143.17B and revenue of 311.94B. Therefore, the gross margin over that period was 45.9%.

CVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, CVS Health Corporation reported a gross profit of 15.62B and revenue of 100.43B. Therefore, the gross margin over that period was 15.6%.

BACHY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Bank of China Ltd ADR reported an operating income of 74.31B and revenue of 311.94B, resulting in an operating margin of 23.8%.

CVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, CVS Health Corporation reported an operating income of 4.68B and revenue of 100.43B, resulting in an operating margin of 4.7%.

BACHY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Bank of China Ltd ADR reported a net income of 56.29B and revenue of 311.94B, resulting in a net margin of 18.0%.

CVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, CVS Health Corporation reported a net income of 2.94B and revenue of 100.43B, resulting in a net margin of 2.9%.


Frequently Asked Questions


BACHY and CVS have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BACHY has higher volatility (10.00%) compared to CVS (7.04%). In terms of maximum drawdown, BACHY dropped -53.68% vs CVS's -64.07%.

CVS currently has the higher Sharpe Ratio (2.25 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BACHY and CVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer